Publication

Bell ML, Fiero MH, Dhillon HM, Bray VJ, Vardy JL. 2017. Statistical controversies in cancer research: using standardized effect size graphs to enhance interpretability of cancer-related clinical trials with patient-reported outcomes. Ann Oncol. 28:1730–1733. doi:10.1093/annonc/mdx064.

Geisler CE, Renquist BJ. 2017. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones. J Endocrinol. 234:R1-R21. doi:10.1530/JOE-16-0513.

Ozdilek BA, Thompson VF, Ahmed NS, White CI, Batey RT, Schwartz JC. 2017. Intrinsically disordered RGG/RG domains mediate degenerate specificity in RNA binding. Nucleic Acids Res. 45:7984–7996. doi:10.1093/nar/gkx460.

Weiss GJ, Waypa J, Blaydorn L, Coats J, McGahey K, Sangal A, Niu J, Lynch CA, Farley JH, Khemka V. 2017. A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus). Br J Cancer. 117:33–40. doi:10.1038/bjc.2017.145.

Smeester L, Bommarito PA, Martin EM, Recio-Vega R, Gonzalez-Cortes T, Olivas-Calderon E, Clark Lantz R, Fry RC. 2017. Chronic early childhood exposure to arsenic is associated with a TNF-mediated proteomic signaling response. Environ Toxicol Pharmacol. 52:183–187. doi:10.1016/j.etap.2017.04.007.

Carew JS, Espitia CM, Zhao W, Han Y, Visconte V, Phillips J, Nawrocki ST. 2017. Disruption of Autophagic Degradation with ROC-325 Antagonizes Renal Cell Carcinoma Pathogenesis. Clin Cancer Res. 23:2869–2879. doi:10.1158/1078-0432.CCR-16-1742.

Romagnolo DF, Donovan MG, Papoutsis AJ, Doetschman TC, Selmin OI. 2017. Genistein Prevents CpG Methylation and Proliferation in Human Breast Cancer Cells with Activated Aromatic Hydrocarbon Receptor. Curr Dev Nutr. 1:e000562. doi:10.3945/cdn.117.000562.

Frank SB, Berger PL, Ljungman M, Miranti CK. 2017. Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC. J Cell Sci. 130:1952–1964. doi:10.1242/jcs.197152.

Jim V, LaViolette C, Briehl MM, Ingram JC. 2017. Spatial distribution of uranium in mice kidneys detected by laser ablation inductively coupled plasma mass spectrometry. J Appl Bioanal. 3:43–48. doi:10.17145/jab.17.007.

Shi L, Vedantham S, Karellas A, Zhu L. 2017. X-ray scatter correction for dedicated cone beam breast CT using a forward-projection model. Med Phys. 44:2312–2320. doi:10.1002/mp.12213.

Aydin I, Villalonga-Planells R, Greune L, Bronnimann MP, Calton CM, Becker M, Lai K-Y, Campos SK, Schmidt MA, Schelhaas M. 2017. A central region in the minor capsid protein of papillomaviruses facilitates viral genome tethering and membrane penetration for mitotic nuclear entry. PLoS Pathog. 13:e1006308. doi:10.1371/journal.ppat.1006308.

Rasmussen LM, Sen N, Vera JC, Liu X, Craig ZR. 2017. Effects of in vitro exposure to dibutyl phthalate, mono-butyl phthalate, and acetyl tributyl citrate on ovarian antral follicle growth and viability. Biol Reprod. 96:1105–1117. doi:10.1095/biolreprod.116.144691.

Kim Y, Huynh JW-Y, Gonzalez VJ. 2017. Evaluation of impact of an external breast shield (FlexiShield) in electronic brachytherapy for breast IORT: A phantom study. Brachytherapy. 16:597–607. doi:10.1016/j.brachy.2017.01.009.

Teye EK, Sido A, Xin P, Finnberg NK, Gokare P, Kawasawa YI, Salzberg AC, Shimko S, Bayerl M, Ehmann WC, et al. 2017. PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features. Oncotarget. 8:29887–29905. doi:10.18632/oncotarget.15136.

Slane BG, Goyal U, Grow JL, Morrison C, Hullett CR, Gordon J, Sanan A, Stea B. 2017. Radiotherapeutic management of vestibular schwannomas using size- and location-adapted fractionation regimens to maximize the therapeutic ratio. Pract Radiat Oncol. 7:e233-e241. doi:10.1016/j.prro.2016.10.016.

Sells E, Pandey R, Chen H, Skovan BA, Cui H, Ignatenko NA. 2017. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6. Neoplasia. 19:396–411. doi:10.1016/j.neo.2017.02.003.

Padi SKR, Luevano LA, An N, Pandey R, Singh N, Song JH, Aster JC, Yu X-Z, Mehrotra S, Kraft AS. 2017. Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset. Oncotarget. 8:30199–30216. doi:10.18632/oncotarget.16320.

Calton CM, Bronnimann MP, Manson AR, Li S, Chapman JA, Suarez-Berumen M, Williamson TR, Molugu SK, Bernal RA, Campos SK. 2017. Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis. PLoS Pathog. 13:e1006200. doi:10.1371/journal.ppat.1006200.

Bruce DW, Stefanski HE, Vincent BG, Dant TA, Reisdorf S, Bommiasamy H, Serody DA, Wilson JE, McKinnon KP, Shlomchik WD, et al. 2017. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 127:1813–1825. doi:10.1172/JCI91816.

Cheung MK, Ong SY, Goyal U, Wertheim BC, Hsu CC, Yi SK. 2017. False Positive Positron Emission Tomography / Computed Tomography Scans in Treated Head and Neck Cancers. Cureus. 9:e1146. doi:10.7759/cureus.1146.

Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O’Sullivan B, Burtness BA, Butterfield LH, Carson WE, et al. 2017. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer. 123:1259–1271. doi:10.1002/cncr.30449.

Gonzalez VJ, Hullett CR, Burt L, Rassiah-Szegedi P, Sarkar V, Tward JD, Hazard LJ, Huang YJ, Salter BJ, Gaffney DK. 2017. Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy. Adv Radiat Oncol. 2:235–243. doi:10.1016/j.adro.2017.01.005.

Rogers JE, Bolonesi RM, Rashid A, Elsayes KM, Elbanan MG, Law L, Kaseb A, Shroff RT. 2017. Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy. J Gastrointest Oncol. 8:347–351. doi:10.21037/jgo.2017.03.03.

Doetschman T, Georgieva T. 2017. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease. Circ Res. 120:876–894. doi:10.1161/CIRCRESAHA.116.309727.

Patel S, Demanes DJ, Ragab O, Zhang M, Veruttipong D, Nguyen K, Park S-J, Marks L, Pantuck A, Steinberg M, et al. 2017. High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer. Brachytherapy. 16:299–305. doi:10.1016/j.brachy.2016.11.002.